• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

截至2007年全球基因治疗临床试验——最新情况

Gene therapy clinical trials worldwide to 2007--an update.

作者信息

Edelstein Michael L, Abedi Mohammad R, Wixon Jo

机构信息

Hemel Hempstead Hospital, Hillfield Road, Hemel Hempstead HP2 4AD, UK.

出版信息

J Gene Med. 2007 Oct;9(10):833-42. doi: 10.1002/jgm.1100.

DOI:10.1002/jgm.1100
PMID:17721874
Abstract

To date, over 1340 gene therapy clinical trials have been completed, are ongoing or have been approved worldwide. In 1997 we set up a database to bring together global information on gene therapy clinical trials as comprehensively as possible. The data are compiled and regularly updated from official agency sources, published literature, conference presentations and posters and from information kindly provided by investigators or trial sponsors themselves. This review updates our descriptive overview of the data in 2004 1, presenting our analysis of the clinical trials that, to the best of our knowledge, have been or are being performed worldwide. As of July 30 2007, we have stored entries on 1309 trials in 28 countries. We have analyzed the geographical distribution of trials, the disease indications (or other reasons) for trials, the proportions to which different vector types are used, and which genes have been transferred. Details of the analyses presented, and our interactive, searchable database can be found on The Journal of Gene Medicine Gene Therapy Clinical Trials Worldwide website at: http://www.wiley.co.uk/genmed/clinical.

摘要

迄今为止,全球已完成、正在进行或已获批的基因治疗临床试验超过1340项。1997年,我们建立了一个数据库,尽可能全面地汇总全球基因治疗临床试验信息。数据来自官方机构来源、已发表文献、会议报告和海报,以及研究人员或试验申办方自行提供的信息,并进行汇编和定期更新。本综述更新了我们在2004年对数据的描述性概述,呈现了我们对据我们所知在全球已开展或正在开展的临床试验的分析。截至2007年7月30日,我们已存储了28个国家1309项试验的条目。我们分析了试验的地理分布、试验的疾病适应症(或其他原因)、不同载体类型的使用比例以及已转移的基因。所呈现分析的详细内容以及我们可交互式搜索的数据库可在《基因医学杂志》全球基因治疗临床试验网站上找到:http://www.wiley.co.uk/genmed/clinical 。

相似文献

1
Gene therapy clinical trials worldwide to 2007--an update.截至2007年全球基因治疗临床试验——最新情况
J Gene Med. 2007 Oct;9(10):833-42. doi: 10.1002/jgm.1100.
2
Gene therapy clinical trials worldwide 1989-2004-an overview.1989 - 2004年全球基因治疗临床试验综述
J Gene Med. 2004 Jun;6(6):597-602. doi: 10.1002/jgm.619.
3
Gene therapy clinical trials worldwide to 2012 - an update.全球 2012 年之前的基因治疗临床试验-更新。
J Gene Med. 2013 Feb;15(2):65-77. doi: 10.1002/jgm.2698.
4
Gene therapy clinical trials worldwide to 2017: An update.基因治疗临床试验全球更新至 2017 年
J Gene Med. 2018 May;20(5):e3015. doi: 10.1002/jgm.3015. Epub 2018 Apr 19.
5
Gene therapy clinical trials worldwide to 2023-an update.全球基因治疗临床试验至 2023 年的更新。
J Gene Med. 2024 Aug;26(8):e3721. doi: 10.1002/jgm.3721.
6
Gene therapy: concepts and methods. Few applications so far.基因治疗:概念与方法。迄今为止应用较少。
Prescrire Int. 2009 Dec;18(104):276-9.
7
Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report.AdGFPFasL与神经酰胺代谢小分子抑制剂联合用于前列腺癌和头颈癌的治疗:现状报告
Cancer Gene Ther. 2006 Dec;13(12):1045-51. doi: 10.1038/sj.cgt.7700965. Epub 2006 Jun 9.
8
An inventory of shedding data from clinical gene therapy trials.临床基因治疗试验中脱落数据的清单。
J Gene Med. 2007 Oct;9(10):910-21. doi: 10.1002/jgm.1096.
9
Gene transfer and therapy clinical trials--update. Part I: Countries, diseases, clinical trial phases, routes of administration.
J Gene Med. 1999 Jan-Feb;1(1):71-3. doi: 10.1002/(SICI)1521-2254(199901/02)1:1<71::AID-JGM10>3.0.CO;2-A.
10
[Viral vectors for clinical gene therapy].[用于临床基因治疗的病毒载体]
Ugeskr Laeger. 2002 Sep 9;164(37):4272-6.

引用本文的文献

1
The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping.基因治疗时代:慢病毒载体及其假型化的进展
Viruses. 2025 Jul 24;17(8):1036. doi: 10.3390/v17081036.
2
Vascular endothelial cell injury: causes, molecular mechanisms, and treatments.血管内皮细胞损伤:原因、分子机制及治疗方法。
MedComm (2020). 2025 Jan 16;6(2):e70057. doi: 10.1002/mco2.70057. eCollection 2025 Feb.
3
A review of temporal interference, nanoparticles, ultrasound, gene therapy, and designer receptors for Parkinson disease.帕金森病的时间干扰、纳米颗粒、超声、基因治疗及定制受体综述。
NPJ Parkinsons Dis. 2024 Oct 23;10(1):195. doi: 10.1038/s41531-024-00804-0.
4
Construction and utilization of a new generation of bacteriophage-based particles, or TPA, for guided systemic delivery of nucleic acids to tumors.构建并利用新一代基于噬菌体的颗粒(即TPA),用于将核酸定向全身递送至肿瘤。
Nat Protoc. 2024 Sep 5. doi: 10.1038/s41596-024-01040-9.
5
Gene therapy for retinal diseases: From genetics to treatment.基因治疗视网膜疾病:从遗传学角度到治疗方法。
Indian J Ophthalmol. 2024 Aug 1;72(8):1091-1101. doi: 10.4103/IJO.IJO_2902_23. Epub 2024 Jul 29.
6
Mechanism of Cationic Lipid Induced DNA Condensation: Lipid-DNA Coordination and Divalent Cation Charge Fluctuations.阳离子脂质诱导 DNA 凝聚的机制:脂质-DNA 配位和二价阳离子电荷波动。
Biomacromolecules. 2024 Aug 12;25(8):4819-4830. doi: 10.1021/acs.biomac.4c00192. Epub 2024 Jul 16.
7
Gene Therapy for Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征的基因治疗
Front Physiol. 2022 Jan 17;12:786255. doi: 10.3389/fphys.2021.786255. eCollection 2021.
8
Advanced Microfluidic Technologies for Lipid Nano-Microsystems from Synthesis to Biological Application.用于脂质纳米微系统从合成到生物应用的先进微流控技术
Pharmaceutics. 2022 Jan 7;14(1):141. doi: 10.3390/pharmaceutics14010141.
9
Towards translational optogenetics.走向转化光遗传学。
Nat Biomed Eng. 2023 Apr;7(4):349-369. doi: 10.1038/s41551-021-00829-3. Epub 2022 Jan 13.
10
Pleiotropy or linkage? Their relative contributions to the genetic correlation of quantitative traits and detection by multitrait GWA studies.多效性还是连锁?它们对数量性状遗传相关的相对贡献和多性状 GWAS 研究的检测。
Genetics. 2021 Dec 10;219(4). doi: 10.1093/genetics/iyab159.